Table 1. Patient demographics and tumor characteristics.

Variable	Overall	Not progressed	Progressed	p-value
No. of cases	37 (100)	31 (83.8)	6 (16.2)	-
Age at presentation (y)	64 (30–86)	65 (37–86)	59 (30–82)	0.967
Male sex	26 (70.3)	22 (71.0)	4 (66.7)	0.833
No. of diabetes	7 (18.9)	5 (16.1)	2 (33.3)	0.315
No. of hypertensions	14 (37.8)	14 (45.2)	2 (33.3)	0.680
Charlson comorbidity index				0.964
0	5 (13.5)	4 (12.9)	1 (16.7)
1–2	25 (67.6)	21 (67.7)	4 (66.7)
≥3	7 (18.9)	6 (19.4)	1 (16.7)
Initial size (mm)	18 (6–28)	17 (6–28)	21 (17–26)	0.091
No. of solid masses	31 (83.8)	25 (80.6)	6 (100)	0.239
Growth rate (mm/y)	2.3 (0–19.0)	0.9 (0–3.0)	9.6 (5.3–19.0)	<0.001
No. of biopsies	12 (32.4)	7 (22.6)	5 (83.3)	<0.001
No. of active interventions	3 (8.1)	0 (0)	3 (50.0)	<0.001
Follow-up duration (mo)	28 (6–80)	29 (6–80)	23 (12–41)	0.773

Values are presented as number (%) or mean (range).